NEW YORK, Oct. 9 – LifeSpan BioSciences of Seattle said Tuesday it had signed Aventis Pharma as its sixth subscriber to its G protein-coupled receptors database.

The database Lifespan will provide to Aventis of Strasbourg, France, includes information on non-olfactory GPCRs. The database, which is designed to help users to identify and prioritize potential drug targets, was designed to be used by Aventis’ branches in the US, Germany, and France.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.